NO831466L - Nye derivater av aren- og heteroaren-karboksamider - Google Patents
Nye derivater av aren- og heteroaren-karboksamiderInfo
- Publication number
- NO831466L NO831466L NO831466A NO831466A NO831466L NO 831466 L NO831466 L NO 831466L NO 831466 A NO831466 A NO 831466A NO 831466 A NO831466 A NO 831466A NO 831466 L NO831466 L NO 831466L
- Authority
- NO
- Norway
- Prior art keywords
- isoquinoline
- group
- phenyl
- carbon atoms
- methyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 43
- 125000004432 carbon atom Chemical group C* 0.000 claims description 23
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 14
- 229910052757 nitrogen Inorganic materials 0.000 claims description 14
- 229960003529 diazepam Drugs 0.000 claims description 10
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 9
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 8
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 8
- 150000001412 amines Chemical class 0.000 claims description 7
- 229940049706 benzodiazepine Drugs 0.000 claims description 7
- 150000001557 benzodiazepines Chemical class 0.000 claims description 7
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 230000007812 deficiency Effects 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 125000000304 alkynyl group Chemical group 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 230000002526 effect on cardiovascular system Effects 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 230000001900 immune effect Effects 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 230000001575 pathological effect Effects 0.000 claims description 2
- 125000003884 phenylalkyl group Chemical group 0.000 claims description 2
- 230000002685 pulmonary effect Effects 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 125000001544 thienyl group Chemical group 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 99
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 60
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 58
- 239000000155 melt Substances 0.000 description 35
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 32
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 28
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 26
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- -1 phenylpyridyl Chemical group 0.000 description 14
- 238000001953 recrystallisation Methods 0.000 description 13
- JBRVJPXJLHEUND-UHFFFAOYSA-N 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid Chemical compound N=1C(C(=O)O)=CC2=CC=CC=C2C=1C1=CC=CC=C1Cl JBRVJPXJLHEUND-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 238000004587 chromatography analysis Methods 0.000 description 11
- PZXFZSUYCIHENQ-UHFFFAOYSA-N 1-phenylisoquinoline-3-carboxylic acid Chemical compound N=1C(C(=O)O)=CC2=CC=CC=C2C=1C1=CC=CC=C1 PZXFZSUYCIHENQ-UHFFFAOYSA-N 0.000 description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- 238000002844 melting Methods 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 7
- 230000002093 peripheral effect Effects 0.000 description 7
- FVXDWWZNKFTQPT-UHFFFAOYSA-N 4-(4-methoxyphenyl)quinoline-2-carboxylic acid Chemical compound C1=CC(OC)=CC=C1C1=CC(C(O)=O)=NC2=CC=CC=C12 FVXDWWZNKFTQPT-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- PYFSCIWXNSXGNS-RXMQYKEDSA-N (2r)-n-methylbutan-2-amine Chemical compound CC[C@@H](C)NC PYFSCIWXNSXGNS-RXMQYKEDSA-N 0.000 description 5
- PYFSCIWXNSXGNS-UHFFFAOYSA-N N-methyl-sec-butylamine Natural products CCC(C)NC PYFSCIWXNSXGNS-UHFFFAOYSA-N 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 239000012442 inert solvent Substances 0.000 description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 5
- 235000019341 magnesium sulphate Nutrition 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 102000005962 receptors Human genes 0.000 description 5
- 108020003175 receptors Proteins 0.000 description 5
- BRIQVMVBEYRTPX-UHFFFAOYSA-N 4-phenylnaphthalene-2-carboxylic acid Chemical compound C=12C=CC=CC2=CC(C(=O)O)=CC=1C1=CC=CC=C1 BRIQVMVBEYRTPX-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- FERUOSAIKDKVPU-UHFFFAOYSA-N 1-(2-chlorophenyl)-7-methylisoquinoline-3-carboxylic acid Chemical compound C12=CC(C)=CC=C2C=C(C(O)=O)N=C1C1=CC=CC=C1Cl FERUOSAIKDKVPU-UHFFFAOYSA-N 0.000 description 3
- JKUQKAGFVASRKW-UHFFFAOYSA-N 4-phenylquinazoline-2-carboxylic acid Chemical compound C=12C=CC=CC2=NC(C(=O)O)=NC=1C1=CC=CC=C1 JKUQKAGFVASRKW-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 102000004300 GABA-A Receptors Human genes 0.000 description 3
- 108090000839 GABA-A Receptors Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- FLORUWDSYNSEAH-UHFFFAOYSA-N (2-aminophenyl)-(4-methoxyphenyl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1N FLORUWDSYNSEAH-UHFFFAOYSA-N 0.000 description 2
- SKNHSOYBCNXIAW-UHFFFAOYSA-N 1-(2-chlorophenyl)-n,n-di(propan-2-yl)isoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(C(C)C)C(C)C)=CC2=CC=CC=C2C=1C1=CC=CC=C1Cl SKNHSOYBCNXIAW-UHFFFAOYSA-N 0.000 description 2
- XCSLCJCCJCTYFI-UHFFFAOYSA-N 1-(2-chlorophenyl)-n,n-diethyl-7-methylisoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(CC)CC)=CC2=CC=C(C)C=C2C=1C1=CC=CC=C1Cl XCSLCJCCJCTYFI-UHFFFAOYSA-N 0.000 description 2
- AXZSDFBOUIQTKT-UHFFFAOYSA-N 1-(2-chlorophenyl)-n,n-diethylisoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(CC)CC)=CC2=CC=CC=C2C=1C1=CC=CC=C1Cl AXZSDFBOUIQTKT-UHFFFAOYSA-N 0.000 description 2
- VYIZWAUOXVCBBY-UHFFFAOYSA-N 1-(2-fluorophenyl)isoquinoline-3-carboxylic acid Chemical compound N=1C(C(=O)O)=CC2=CC=CC=C2C=1C1=CC=CC=C1F VYIZWAUOXVCBBY-UHFFFAOYSA-N 0.000 description 2
- CJSYHLTUFJVZGX-UHFFFAOYSA-N 1-(3-chlorophenyl)-n,n-diethylisoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(CC)CC)=CC2=CC=CC=C2C=1C1=CC=CC(Cl)=C1 CJSYHLTUFJVZGX-UHFFFAOYSA-N 0.000 description 2
- GXZOYJFPIYDIKX-UHFFFAOYSA-N 1-(3-chlorophenyl)isoquinoline-3-carboxylic acid Chemical compound N=1C(C(=O)O)=CC2=CC=CC=C2C=1C1=CC=CC(Cl)=C1 GXZOYJFPIYDIKX-UHFFFAOYSA-N 0.000 description 2
- SGFZBYXRNYXSEN-UHFFFAOYSA-N 1-(3-fluorophenyl)isoquinoline-3-carboxylic acid Chemical compound N=1C(C(=O)O)=CC2=CC=CC=C2C=1C1=CC=CC(F)=C1 SGFZBYXRNYXSEN-UHFFFAOYSA-N 0.000 description 2
- WUAIAFGRLRKGIH-UHFFFAOYSA-N 1-(4-chlorophenyl)isoquinoline-3-carboxylic acid Chemical compound N=1C(C(=O)O)=CC2=CC=CC=C2C=1C1=CC=C(Cl)C=C1 WUAIAFGRLRKGIH-UHFFFAOYSA-N 0.000 description 2
- LYBFJSVPDRRTQX-UHFFFAOYSA-N 1-(4-methylphenyl)isoquinoline-3-carboxylic acid Chemical compound C1=CC(C)=CC=C1C1=NC(C(O)=O)=CC2=CC=CC=C12 LYBFJSVPDRRTQX-UHFFFAOYSA-N 0.000 description 2
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 2
- ATBODLURBKBOFS-UHFFFAOYSA-N 1-thiophen-2-ylisoquinoline-3-carboxylic acid Chemical compound N=1C(C(=O)O)=CC2=CC=CC=C2C=1C1=CC=CS1 ATBODLURBKBOFS-UHFFFAOYSA-N 0.000 description 2
- JCXVNZUDGWUUIY-UHFFFAOYSA-N 2-methyl-4-(3-nitrophenyl)quinoline Chemical compound C=12C=CC=CC2=NC(C)=CC=1C1=CC=CC([N+]([O-])=O)=C1 JCXVNZUDGWUUIY-UHFFFAOYSA-N 0.000 description 2
- KYRUSDPKYCDJOT-UHFFFAOYSA-N 4-(2-fluorophenyl)-2-(tribromomethyl)quinoline Chemical compound FC1=CC=CC=C1C1=CC(C(Br)(Br)Br)=NC2=CC=CC=C12 KYRUSDPKYCDJOT-UHFFFAOYSA-N 0.000 description 2
- MNKNKDUNEOCKBX-UHFFFAOYSA-N 4-(2-fluorophenyl)-2-methylquinoline Chemical compound C=12C=CC=CC2=NC(C)=CC=1C1=CC=CC=C1F MNKNKDUNEOCKBX-UHFFFAOYSA-N 0.000 description 2
- WNKPMFHJELPMSG-UHFFFAOYSA-N 4-(2-fluorophenyl)quinoline-2-carboxylic acid Chemical compound C=12C=CC=CC2=NC(C(=O)O)=CC=1C1=CC=CC=C1F WNKPMFHJELPMSG-UHFFFAOYSA-N 0.000 description 2
- GRHDJSACRWDRGI-UHFFFAOYSA-N 4-(3-nitrophenyl)quinoline-2-carboxylic acid Chemical compound C=12C=CC=CC2=NC(C(=O)O)=CC=1C1=CC=CC([N+]([O-])=O)=C1 GRHDJSACRWDRGI-UHFFFAOYSA-N 0.000 description 2
- PVDRIRXRKDWECV-UHFFFAOYSA-N 4-(4-methoxyphenyl)-2-methylquinoline Chemical compound C1=CC(OC)=CC=C1C1=CC(C)=NC2=CC=CC=C12 PVDRIRXRKDWECV-UHFFFAOYSA-N 0.000 description 2
- IBXMDQVFEDWKBY-UHFFFAOYSA-N 4-phenylquinoline-2-carboxylic acid Chemical compound C=12C=CC=CC2=NC(C(=O)O)=CC=1C1=CC=CC=C1 IBXMDQVFEDWKBY-UHFFFAOYSA-N 0.000 description 2
- DOXMHOVUJBKKRK-UHFFFAOYSA-N 7-chloro-1-(2-chlorophenyl)-n,n-diethylisoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(CC)CC)=CC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1Cl DOXMHOVUJBKKRK-UHFFFAOYSA-N 0.000 description 2
- GOWNRPOVEQSARC-UHFFFAOYSA-N 7-chloro-1-(2-chlorophenyl)isoquinoline-3-carboxylic acid Chemical compound N=1C(C(=O)O)=CC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1Cl GOWNRPOVEQSARC-UHFFFAOYSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QHNXSGKJSCJBQP-IBGZPJMESA-N [(2s)-2-ethylpiperidin-1-yl]-(1-phenylisoquinolin-3-yl)methanone Chemical compound CC[C@H]1CCCCN1C(=O)C1=CC2=CC=CC=C2C(C=2C=CC=CC=2)=N1 QHNXSGKJSCJBQP-IBGZPJMESA-N 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 239000001961 anticonvulsive agent Substances 0.000 description 2
- 239000002249 anxiolytic agent Substances 0.000 description 2
- 230000000949 anxiolytic effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- ICBNZSHUWSBMCL-UHFFFAOYSA-N butan-2-yl(methyl)azanium;chloride Chemical compound Cl.CCC(C)NC ICBNZSHUWSBMCL-UHFFFAOYSA-N 0.000 description 2
- 150000003857 carboxamides Chemical class 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 2
- 229960003120 clonazepam Drugs 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 2
- XYRMBIPURWBFEP-UHFFFAOYSA-N ethyl 1-(2-chlorophenyl)isoquinoline-3-carboxylate Chemical compound N=1C(C(=O)OCC)=CC2=CC=CC=C2C=1C1=CC=CC=C1Cl XYRMBIPURWBFEP-UHFFFAOYSA-N 0.000 description 2
- HJIBOPNZOFCIEZ-UHFFFAOYSA-N ethyl 6,7-dimethoxy-1-phenylisoquinoline-3-carboxylate Chemical compound N=1C(C(=O)OCC)=CC2=CC(OC)=C(OC)C=C2C=1C1=CC=CC=C1 HJIBOPNZOFCIEZ-UHFFFAOYSA-N 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- XZPPINNSBJRCTE-UHFFFAOYSA-N n,n-dibutyl-1-phenylisoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(CCCC)CCCC)=CC2=CC=CC=C2C=1C1=CC=CC=C1 XZPPINNSBJRCTE-UHFFFAOYSA-N 0.000 description 2
- WPIXGZVJJBQKDB-UHFFFAOYSA-N n,n-diethyl-1-(4-methylphenyl)isoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(CC)CC)=CC2=CC=CC=C2C=1C1=CC=C(C)C=C1 WPIXGZVJJBQKDB-UHFFFAOYSA-N 0.000 description 2
- RCNKYZDTMYDXSE-UHFFFAOYSA-N n,n-diethyl-1-phenylisoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(CC)CC)=CC2=CC=CC=C2C=1C1=CC=CC=C1 RCNKYZDTMYDXSE-UHFFFAOYSA-N 0.000 description 2
- MDTYGTRMNOXTQN-UHFFFAOYSA-N n,n-diethyl-6,7-dimethoxy-1-phenylisoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(CC)CC)=CC2=CC(OC)=C(OC)C=C2C=1C1=CC=CC=C1 MDTYGTRMNOXTQN-UHFFFAOYSA-N 0.000 description 2
- XCGFVFIAUFWTHT-UHFFFAOYSA-N n-benzyl-1-(2-chlorophenyl)-n-methylisoquinoline-3-carboxamide Chemical compound C=1C2=CC=CC=C2C(C=2C(=CC=CC=2)Cl)=NC=1C(=O)N(C)CC1=CC=CC=C1 XCGFVFIAUFWTHT-UHFFFAOYSA-N 0.000 description 2
- XEUJNAHGAYFATG-UHFFFAOYSA-N n-butan-2-yl-n-methyl-1-phenylisoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(C)C(C)CC)=CC2=CC=CC=C2C=1C1=CC=CC=C1 XEUJNAHGAYFATG-UHFFFAOYSA-N 0.000 description 2
- ZMHLRZBBYFSEQU-UHFFFAOYSA-N n-butan-2-yl-n-methyl-4-phenylnaphthalene-2-carboxamide Chemical compound C=12C=CC=CC2=CC(C(=O)N(C)C(C)CC)=CC=1C1=CC=CC=C1 ZMHLRZBBYFSEQU-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- NRAJMXHXQHCBHO-UHFFFAOYSA-N (2-aminophenyl)-(2-fluorophenyl)methanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=C1F NRAJMXHXQHCBHO-UHFFFAOYSA-N 0.000 description 1
- MAOBFOXLCJIFLV-UHFFFAOYSA-N (2-aminophenyl)-phenylmethanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=C1 MAOBFOXLCJIFLV-UHFFFAOYSA-N 0.000 description 1
- QHNXSGKJSCJBQP-UHFFFAOYSA-N (2-ethylpiperidin-1-yl)-(1-phenylisoquinolin-3-yl)methanone Chemical compound CCC1CCCCN1C(=O)C1=CC2=CC=CC=C2C(C=2C=CC=CC=2)=N1 QHNXSGKJSCJBQP-UHFFFAOYSA-N 0.000 description 1
- ICBNZSHUWSBMCL-NUBCRITNSA-N (2R)-N-methylbutan-2-amine hydrochloride Chemical compound Cl.CN[C@H](C)CC ICBNZSHUWSBMCL-NUBCRITNSA-N 0.000 description 1
- HFEDNVOKYCDBFD-OGFXRTJISA-N (2r)-2-ethylpiperidine;hydrochloride Chemical compound Cl.CC[C@@H]1CCCCN1 HFEDNVOKYCDBFD-OGFXRTJISA-N 0.000 description 1
- QBBKKFZGCDJDQK-ZETCQYMHSA-N (2s)-2-ethylpiperidine Chemical compound CC[C@H]1CCCCN1 QBBKKFZGCDJDQK-ZETCQYMHSA-N 0.000 description 1
- PYFSCIWXNSXGNS-YFKPBYRVSA-N (2s)-n-methylbutan-2-amine Chemical compound CC[C@H](C)NC PYFSCIWXNSXGNS-YFKPBYRVSA-N 0.000 description 1
- RNHDAKUGFHSZEV-UHFFFAOYSA-N 1,4-dioxane;hydrate Chemical compound O.C1COCCO1 RNHDAKUGFHSZEV-UHFFFAOYSA-N 0.000 description 1
- ROQAEKBEGAOJGU-UHFFFAOYSA-N 1-(2-chlorophenyl)-n,n-dipropylisoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(CCC)CCC)=CC2=CC=CC=C2C=1C1=CC=CC=C1Cl ROQAEKBEGAOJGU-UHFFFAOYSA-N 0.000 description 1
- AKCGLLSNHQAHJT-UHFFFAOYSA-N 1-(2-chlorophenyl)-n-cyclohexyl-n-methylisoquinoline-3-carboxamide Chemical compound C=1C2=CC=CC=C2C(C=2C(=CC=CC=2)Cl)=NC=1C(=O)N(C)C1CCCCC1 AKCGLLSNHQAHJT-UHFFFAOYSA-N 0.000 description 1
- RMAMAMIWOLBTTC-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-methylisoquinoline Chemical compound N=1C(C)=CC2=CC=CC=C2C=1C1=CC=C(Cl)C=C1 RMAMAMIWOLBTTC-UHFFFAOYSA-N 0.000 description 1
- DIKPMXPRNPSFJD-UHFFFAOYSA-N 1-(4-chlorophenyl)-n,n-diethylisoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(CC)CC)=CC2=CC=CC=C2C=1C1=CC=C(Cl)C=C1 DIKPMXPRNPSFJD-UHFFFAOYSA-N 0.000 description 1
- DXYPARROGCAXAE-UHFFFAOYSA-N 1-[3-(trifluoromethyl)phenyl]isoquinoline-3-carboxylic acid Chemical compound N=1C(C(=O)O)=CC2=CC=CC=C2C=1C1=CC=CC(C(F)(F)F)=C1 DXYPARROGCAXAE-UHFFFAOYSA-N 0.000 description 1
- FQNBYCBCFDMMKA-UHFFFAOYSA-N 2-(2-chlorophenyl)-4-(thiophen-2-ylmethylidene)-1,3-oxazol-5-one Chemical compound ClC1=CC=CC=C1C(OC1=O)=NC1=CC1=CC=CS1 FQNBYCBCFDMMKA-UHFFFAOYSA-N 0.000 description 1
- NDHVFVOIJJCBNY-UHFFFAOYSA-N 2-(2-chlorophenyl)-4-[(4-methylphenyl)methylidene]-1,3-oxazol-5-one Chemical compound C1=CC(C)=CC=C1C=C1C(=O)OC(C=2C(=CC=CC=2)Cl)=N1 NDHVFVOIJJCBNY-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- QBBKKFZGCDJDQK-UHFFFAOYSA-N 2-ethylpiperidine Chemical compound CCC1CCCCN1 QBBKKFZGCDJDQK-UHFFFAOYSA-N 0.000 description 1
- LBDODDLWQDVLIH-UHFFFAOYSA-N 2-methyl-3-phenylquinoline Chemical compound CC1=NC2=CC=CC=C2C=C1C1=CC=CC=C1 LBDODDLWQDVLIH-UHFFFAOYSA-N 0.000 description 1
- MBXIOFXLAGTBGI-UHFFFAOYSA-N 2-methyl-4-phenylquinoline Chemical compound C=12C=CC=CC2=NC(C)=CC=1C1=CC=CC=C1 MBXIOFXLAGTBGI-UHFFFAOYSA-N 0.000 description 1
- YWWRMWAWBUHZAY-UHFFFAOYSA-N 2-phenyl-4-(thiophen-2-ylmethylidene)-1,3-oxazol-5-one Chemical compound O=C1OC(C=2C=CC=CC=2)=NC1=CC1=CC=CS1 YWWRMWAWBUHZAY-UHFFFAOYSA-N 0.000 description 1
- VJRCBZGNLMQBNZ-UHFFFAOYSA-N 2-phenyl-4-(thiophen-3-ylmethylidene)-1,3-oxazol-5-one Chemical compound O=C1OC(C=2C=CC=CC=2)=NC1=CC=1C=CSC=1 VJRCBZGNLMQBNZ-UHFFFAOYSA-N 0.000 description 1
- PJSMANIZFJODDC-UHFFFAOYSA-N 3-(dibromomethyl)-1-[3-(trifluoromethyl)phenyl]isoquinoline Chemical compound FC(F)(F)C1=CC=CC(C=2C3=CC=CC=C3C=C(N=2)C(Br)Br)=C1 PJSMANIZFJODDC-UHFFFAOYSA-N 0.000 description 1
- FSVQCPHRLVVUBO-UHFFFAOYSA-N 3-methyl-1-[3-(trifluoromethyl)phenyl]isoquinoline Chemical compound N=1C(C)=CC2=CC=CC=C2C=1C1=CC=CC(C(F)(F)F)=C1 FSVQCPHRLVVUBO-UHFFFAOYSA-N 0.000 description 1
- XYVMOLOUBJBNBF-UHFFFAOYSA-N 3h-1,3-oxazol-2-one Chemical class OC1=NC=CO1 XYVMOLOUBJBNBF-UHFFFAOYSA-N 0.000 description 1
- QKGYOCQOMNZHIU-UHFFFAOYSA-N 4-(4-methoxyphenyl)quinoline-2-carbaldehyde Chemical compound C1=CC(OC)=CC=C1C1=CC(C=O)=NC2=CC=CC=C12 QKGYOCQOMNZHIU-UHFFFAOYSA-N 0.000 description 1
- IDWSFHJCPRPACB-UHFFFAOYSA-N 4-benzylidene-2-(2-fluorophenyl)-1,3-oxazol-5-one Chemical compound FC1=CC=CC=C1C(OC1=O)=NC1=CC1=CC=CC=C1 IDWSFHJCPRPACB-UHFFFAOYSA-N 0.000 description 1
- UKSDTQODSUQZKG-UHFFFAOYSA-N 4-benzylidene-2-(3-chlorophenyl)-1,3-oxazol-5-one Chemical compound ClC1=CC=CC(C=2OC(=O)C(=CC=3C=CC=CC=3)N=2)=C1 UKSDTQODSUQZKG-UHFFFAOYSA-N 0.000 description 1
- NYTOKLBYOCWFAC-UHFFFAOYSA-N 4-benzylidene-2-(3-fluorophenyl)-1,3-oxazol-5-one Chemical compound FC1=CC=CC(C=2OC(=O)C(=CC=3C=CC=CC=3)N=2)=C1 NYTOKLBYOCWFAC-UHFFFAOYSA-N 0.000 description 1
- CQBYEKYOZUQQPY-UHFFFAOYSA-N 4-benzylidene-2-(4-methylphenyl)-1,3-oxazol-5-one Chemical compound C1=CC(C)=CC=C1C(OC1=O)=NC1=CC1=CC=CC=C1 CQBYEKYOZUQQPY-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- OWYWGLHRNBIFJP-UHFFFAOYSA-N Ipazine Chemical compound CCN(CC)C1=NC(Cl)=NC(NC(C)C)=N1 OWYWGLHRNBIFJP-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- HCGUIUWTOVSUJU-UHFFFAOYSA-N N,N-diethyl-1-[3-(trifluoromethyl)phenyl]isoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(CC)CC)=CC2=CC=CC=C2C=1C1=CC=CC(C(F)(F)F)=C1 HCGUIUWTOVSUJU-UHFFFAOYSA-N 0.000 description 1
- XTUVJUMINZSXGF-UHFFFAOYSA-N N-methylcyclohexylamine Chemical compound CNC1CCCCC1 XTUVJUMINZSXGF-UHFFFAOYSA-N 0.000 description 1
- PAMIQIKDUOTOBW-UHFFFAOYSA-N N-methylcyclohexylamine Natural products CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- RAVIZVQZGXBOQO-UHFFFAOYSA-N PK-11195 Chemical compound N=1C(C(=O)N(C)C(C)CC)=CC2=CC=CC=C2C=1C1=CC=CC=C1Cl RAVIZVQZGXBOQO-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- PPTYJKAXVCCBDU-UHFFFAOYSA-N Rohypnol Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1F PPTYJKAXVCCBDU-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- JXWKVMZOCWFZLA-UHFFFAOYSA-N [1-(2-chlorophenyl)isoquinolin-3-yl]-piperidin-1-ylmethanone Chemical compound ClC1=CC=CC=C1C1=NC(C(=O)N2CCCCC2)=CC2=CC=CC=C12 JXWKVMZOCWFZLA-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 229940005530 anxiolytics Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000012320 chlorinating reagent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 description 1
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- BJFPYRGLZWUDLP-UHFFFAOYSA-N ethyl 1-phenylisoquinoline-3-carboxylate Chemical compound N=1C(C(=O)OCC)=CC2=CC=CC=C2C=1C1=CC=CC=C1 BJFPYRGLZWUDLP-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 229960002200 flunitrazepam Drugs 0.000 description 1
- OMRRUNXAWXNVFW-UHFFFAOYSA-N fluoridochlorine Chemical compound ClF OMRRUNXAWXNVFW-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- ZXUQEPZWVQIOJE-UHFFFAOYSA-N methyl 2-chloro-2-oxoacetate Chemical compound COC(=O)C(Cl)=O ZXUQEPZWVQIOJE-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- JREUUMJVXSTQIH-UHFFFAOYSA-N n,n-diethyl-1-(3-fluorophenyl)isoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(CC)CC)=CC2=CC=CC=C2C=1C1=CC=CC(F)=C1 JREUUMJVXSTQIH-UHFFFAOYSA-N 0.000 description 1
- LDBRJKPODPREDJ-UHFFFAOYSA-N n,n-diethyl-4-phenylnaphthalene-2-carboxamide Chemical compound C=12C=CC=CC2=CC(C(=O)N(CC)CC)=CC=1C1=CC=CC=C1 LDBRJKPODPREDJ-UHFFFAOYSA-N 0.000 description 1
- IJBAHHOMQMZVRL-UHFFFAOYSA-N n,n-diethyl-4-phenylquinazoline-2-carboxamide Chemical compound C=12C=CC=CC2=NC(C(=O)N(CC)CC)=NC=1C1=CC=CC=C1 IJBAHHOMQMZVRL-UHFFFAOYSA-N 0.000 description 1
- VNGRDQIGMNKAIH-UHFFFAOYSA-N n,n-diethyl-4-phenylquinoline-2-carboxamide Chemical compound C=12C=CC=CC2=NC(C(=O)N(CC)CC)=CC=1C1=CC=CC=C1 VNGRDQIGMNKAIH-UHFFFAOYSA-N 0.000 description 1
- ZXEJBIUBMVRYND-UHFFFAOYSA-N n,n-dimethyl-1-phenylisoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(C)C)=CC2=CC=CC=C2C=1C1=CC=CC=C1 ZXEJBIUBMVRYND-UHFFFAOYSA-N 0.000 description 1
- RAVIZVQZGXBOQO-CQSZACIVSA-N n-[(2r)-butan-2-yl]-1-(2-chlorophenyl)-n-methylisoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(C)[C@H](C)CC)=CC2=CC=CC=C2C=1C1=CC=CC=C1Cl RAVIZVQZGXBOQO-CQSZACIVSA-N 0.000 description 1
- RAVIZVQZGXBOQO-AWEZNQCLSA-N n-[(2s)-butan-2-yl]-1-(2-chlorophenyl)-n-methylisoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(C)[C@@H](C)CC)=CC2=CC=CC=C2C=1C1=CC=CC=C1Cl RAVIZVQZGXBOQO-AWEZNQCLSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- UZYCPQQPCHVGHD-UHFFFAOYSA-N n-butan-2-yl-1-(2-chlorophenyl)-n,7-dimethylisoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(C)C(C)CC)=CC2=CC=C(C)C=C2C=1C1=CC=CC=C1Cl UZYCPQQPCHVGHD-UHFFFAOYSA-N 0.000 description 1
- NIJJHLBYXZSJPD-UHFFFAOYSA-N n-butan-2-yl-n-methyl-1-thiophen-2-ylisoquinoline-3-carboxamide Chemical compound N=1C(C(=O)N(C)C(C)CC)=CC2=CC=CC=C2C=1C1=CC=CS1 NIJJHLBYXZSJPD-UHFFFAOYSA-N 0.000 description 1
- HYTRGVCHLINHFI-UHFFFAOYSA-N n-butan-2-yl-n-methyl-4-phenylquinazoline-2-carboxamide Chemical compound C=12C=CC=CC2=NC(C(=O)N(C)C(C)CC)=NC=1C1=CC=CC=C1 HYTRGVCHLINHFI-UHFFFAOYSA-N 0.000 description 1
- MWZXRLJDNKCYOQ-UHFFFAOYSA-N n-butan-2-ylbutan-1-amine Chemical compound CCCCNC(C)CC MWZXRLJDNKCYOQ-UHFFFAOYSA-N 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- LEBGAAUJVMRKPP-UHFFFAOYSA-N n-methylbut-2-en-2-amine Chemical compound CNC(C)=CC LEBGAAUJVMRKPP-UHFFFAOYSA-N 0.000 description 1
- 230000010807 negative regulation of binding Effects 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- ABABQFDOYCEIRS-UHFFFAOYSA-N piperidin-2-ylidenemethanone Chemical compound O=C=C1CCCCN1 ABABQFDOYCEIRS-UHFFFAOYSA-N 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8207217A FR2525595A1 (fr) | 1982-04-27 | 1982-04-27 | Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO831466L true NO831466L (no) | 1983-10-28 |
Family
ID=9273433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO831466A NO831466L (no) | 1982-04-27 | 1983-04-26 | Nye derivater av aren- og heteroaren-karboksamider |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4499094A (de) |
| EP (1) | EP0094271B1 (de) |
| JP (1) | JPS58201756A (de) |
| AU (1) | AU555417B2 (de) |
| CA (1) | CA1207324A (de) |
| DE (1) | DE3365086D1 (de) |
| DK (1) | DK184783A (de) |
| ES (1) | ES521864A0 (de) |
| FR (1) | FR2525595A1 (de) |
| GR (1) | GR77909B (de) |
| HU (1) | HU189271B (de) |
| IL (1) | IL68326A0 (de) |
| MA (1) | MA19777A1 (de) |
| NO (1) | NO831466L (de) |
| PT (1) | PT76528B (de) |
| ZA (1) | ZA832925B (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2538388B1 (fr) * | 1982-12-24 | 1985-06-21 | Pharmuka Lab | Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments |
| US4649146A (en) * | 1983-01-31 | 1987-03-10 | Fujisawa Pharmaceutical Co., Ltd. | Thiazole derivatives and pharmaceutical composition comprising the same |
| FR2582514B1 (fr) * | 1985-05-30 | 1988-02-19 | Rhone Poulenc Sante | Medicaments a base d'amides, nouveaux amides et leur preparation |
| HU196758B (en) * | 1986-05-21 | 1989-01-30 | Gyogyszerkutato Intezet | Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them |
| DE3752373T2 (de) * | 1986-10-13 | 2004-03-25 | Asahi Kasei Kogyo K.K. | Pyridin-derivate |
| DE3919348A1 (de) * | 1988-06-16 | 1989-12-21 | Ciba Geigy Ag | Mikrobizide mittel |
| US5219864A (en) * | 1991-03-12 | 1993-06-15 | Kyowa Hakko Kogyo Co., Ltd. | Thienopyridine derivatives |
| US5550124A (en) * | 1991-12-10 | 1996-08-27 | University Of Southern California | Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease |
| IL117659A (en) * | 1995-04-13 | 2000-12-06 | Dainippon Pharmaceutical Co | Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same |
| WO1998014213A1 (fr) | 1996-10-01 | 1998-04-09 | Daiichi Pharmaceutical Co., Ltd. | Stabilisateur de la membrane mitochondriale |
| WO1998049155A1 (en) * | 1997-04-25 | 1998-11-05 | Takeda Chemical Industries, Ltd. | Cell differentiation inducing amide derivatives, their production and use |
| AU7474998A (en) * | 1997-05-07 | 1998-11-27 | Emory University | Haloisoquinoline carboxamide |
| ZA9810490B (en) | 1997-12-03 | 1999-05-20 | Dainippon Pharmaceutical Co | 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor |
| WO1999058117A1 (fr) * | 1998-05-13 | 1999-11-18 | Sanofi-Synthelabo | Utilisation de composes reduisant l'apoptose |
| FR2778564B1 (fr) * | 1998-05-13 | 2001-07-13 | Sanofi Sa | Utilisation de composes reduisant l'apoptose |
| DE69926535T2 (de) * | 1998-12-18 | 2006-03-30 | Scios Inc., Sunnyvale | Behandlung von erkrankungen mit zystenbildung |
| GB0516723D0 (en) * | 2005-08-15 | 2005-09-21 | Novartis Ag | Organic compounds |
| WO2008023357A1 (en) | 2006-08-22 | 2008-02-28 | Technion Research And Development Foundation Ltd. | Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr) |
| WO2008063625A2 (en) * | 2006-11-20 | 2008-05-29 | Adolor Corporation | Pyridine compounds and methods of their use |
| EP2228363A4 (de) * | 2007-10-31 | 2011-06-01 | Riken | Kit zur verwendung bei der herstellung einer molekularen sonde zum pet-arzneimittel-screening |
| GB0907284D0 (en) | 2009-04-28 | 2009-06-10 | Queen Mary & Westfield College | Compounds for inducing cellular apoptosis |
| WO2014164678A1 (en) * | 2013-03-12 | 2014-10-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Translocator protein imaging agents; methods of manufacture, and methods of use thereof |
| CN106458933B (zh) | 2014-04-23 | 2021-03-05 | 泰克年研究发展基金会公司 | 基于喹唑啉支架的化合物、其药物组合物及使用方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1069296A (en) * | 1912-07-31 | 1913-08-05 | Hoechst Ag | Derivatives of phenylcinchoninic acid. |
| BE764299A (en) * | 1971-03-12 | 1971-08-16 | Malesci Sas | Antifibrillatory ethylenediamines or imida- - zolines |
| FR2417512A1 (fr) * | 1978-02-17 | 1979-09-14 | Parcor | Thieno (3,2-c) et thieno (2,3-c) pyridines, leur procede de preparation et leur application en therapeutique |
| FR2485014A1 (fr) * | 1980-06-20 | 1981-12-24 | Pharmindustrie | Nouveaux derives de (quinolyl-2, -3 ou -4)-1 (piperidyl ou pyrrolidinyl-2 ou -3)-2 ou -3 ethanone ou propanone, procedes pour leur preparation, et leur utilisation comme medicaments |
-
1982
- 1982-04-27 FR FR8207217A patent/FR2525595A1/fr active Granted
-
1983
- 1983-03-30 GR GR70936A patent/GR77909B/el unknown
- 1983-04-05 US US06/482,082 patent/US4499094A/en not_active Expired - Fee Related
- 1983-04-07 IL IL68326A patent/IL68326A0/xx unknown
- 1983-04-08 PT PT76528A patent/PT76528B/pt unknown
- 1983-04-14 CA CA000425918A patent/CA1207324A/fr not_active Expired
- 1983-04-15 DE DE8383400749T patent/DE3365086D1/de not_active Expired
- 1983-04-15 EP EP83400749A patent/EP0094271B1/de not_active Expired
- 1983-04-25 MA MA19997A patent/MA19777A1/fr unknown
- 1983-04-26 JP JP58073653A patent/JPS58201756A/ja active Granted
- 1983-04-26 HU HU831431A patent/HU189271B/hu unknown
- 1983-04-26 DK DK184783A patent/DK184783A/da not_active Application Discontinuation
- 1983-04-26 NO NO831466A patent/NO831466L/no unknown
- 1983-04-26 ES ES521864A patent/ES521864A0/es active Granted
- 1983-04-26 ZA ZA832925A patent/ZA832925B/xx unknown
- 1983-04-27 AU AU14002/83A patent/AU555417B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| PT76528A (fr) | 1983-05-01 |
| JPH0324467B2 (de) | 1991-04-03 |
| HU189271B (en) | 1986-06-30 |
| FR2525595A1 (fr) | 1983-10-28 |
| PT76528B (fr) | 1985-12-09 |
| EP0094271A2 (de) | 1983-11-16 |
| FR2525595B1 (de) | 1985-03-22 |
| IL68326A0 (en) | 1983-07-31 |
| DK184783A (da) | 1983-10-28 |
| GR77909B (de) | 1984-09-25 |
| AU1400283A (en) | 1983-11-03 |
| CA1207324A (fr) | 1986-07-08 |
| AU555417B2 (en) | 1986-09-25 |
| DE3365086D1 (en) | 1986-09-11 |
| ES8406419A1 (es) | 1984-08-01 |
| EP0094271A3 (en) | 1984-07-04 |
| ES521864A0 (es) | 1984-08-01 |
| EP0094271B1 (de) | 1986-08-06 |
| DK184783D0 (da) | 1983-04-26 |
| US4499094A (en) | 1985-02-12 |
| ZA832925B (en) | 1984-01-25 |
| JPS58201756A (ja) | 1983-11-24 |
| MA19777A1 (fr) | 1983-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO831466L (no) | Nye derivater av aren- og heteroaren-karboksamider | |
| US4684652A (en) | Pharmaceutical compositions containing naphthalene-and azanaphthalene-carboxamide derivatives, new naphthalene-and azanaphthalene-carboxamide derivatives and process for their preparation | |
| AU638795B2 (en) | 3-arylcarbonyl-1h-indoles useful as therapeutic agents | |
| SU1041034A3 (ru) | Способ получени производных пиперидинилалкилхиназолина или их солей с фармацевтически приемлемыми кислотами | |
| DE60129210T2 (de) | Zyklische amid-derivate | |
| RU2088582C1 (ru) | Производные арил-(или гетероарил)- пиперазинилалкилазолов, способ их получения и фармацевтическая композиция на их основе | |
| SU1227109A3 (ru) | Способ получени производных пиперидина или их фармацевтически приемлемых солей | |
| US4472403A (en) | Quinoline derivatives and pharmaceutical compositions and methods for treating cardiovascular disease with such compounds | |
| NO319948B1 (no) | 1-Arensulfonyl-2-aryl-pyrrolidin- og -piperidin-derivater for behandling av CNS-sykdommer | |
| JP2001518906A (ja) | セロトニン様作用薬としてのインダゾールアミド化合物 | |
| NO812105L (no) | Nye derivater av 1-(2-,3- eller 4-kinolyl)-2- eller -3-(2- eller 3-piperidyl eller -pyrrolidinyl) etanon eller propanon, samt deres fremstilling og anvendelse | |
| DD151754A5 (de) | Pyrazolochinoline,verfahren zu ihrer herstellung,pharmazeutische praeparate enthaltend diese verbindungen,sowie ihre therapeutische verwendung | |
| EP0023707B1 (de) | Substituierte Tetraazatricyclen, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel | |
| US4433150A (en) | 2-(4-Piperidyl)-1-(4-quinolyl)-ethanones and ethanes | |
| DE69329084T2 (de) | Benzoxazepin-Derivate als Cholinesterase-Inhibitoren | |
| DE2919800A1 (de) | 4-amino-2-piperidinochinazolin-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel | |
| US5356907A (en) | 1-cycloalkylpyridones as analgesics | |
| NZ243337A (en) | 1-piperidyl substituted quinoline derivatives and pharmaceutical compositions | |
| DK143277B (da) | Analogifremgangsmaade til fremstilling af s-triazolo(1,5-a)(1,4)benzodiazepinderivater eller 5-oxider eller syreadditionssalte deraf | |
| US4515944A (en) | 1,5-Diphenyl-2-haloalkylpyrazolin-3-one intermediates | |
| EP0597540B1 (de) | Aryl und Hetaryl annelierte 2,4-Diazocine als anti-arryhthmische Wirkstoffe | |
| NO893653L (no) | Quinolinderivater og deres fremstilling. | |
| US4046900A (en) | Benzoylpiperidylalkylindoles | |
| AT383347B (de) | Verfahren zur herstellung von neuen aren- und heteroarencarboxamidderivaten | |
| DE69612413T2 (de) | 1-(Hetero)Arylvinyl-5H-2,3-benzodiazepinderivative verwendbar zur Behandlung von Erkrankungen des Zentralnervensystems, sowie Benzopyrylium Intermediate zu ihrer Herstellung |